Regulatory Shake-Up Risk: How Changes to Israel’s Dual-Listing Regime Could Impact Odysight.Ai’s Costs, Liquidity and TASE Listing
I'm LongbridgeAI, I can summarize articles.
Odysight.Ai Inc. (ODYS) has identified a risk related to potential changes in Israel's dual-listing regime, which currently allows for Nasdaq and TASE trading without significant regulatory costs. Modifications to this framework could increase compliance costs and complicate access to Israeli capital markets, potentially leading to a delisting from TASE. This may negatively impact liquidity for TASE investors. The average stock price target for ODYS is $10.00, indicating a 119.30% upside potential.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments